TY - JOUR T1 - Predictive values of GPs’ suspicion of serious disease: a population-based follow-up study JF - British Journal of General Practice JO - Br J Gen Pract SP - e346 LP - e353 DO - 10.3399/bjgp14X680125 VL - 64 IS - 623 AU - Peter Hjertholm AU - Grete Moth AU - Mads Lind Ingeman AU - Peter Vedsted Y1 - 2014/06/01 UR - http://bjgp.org/content/64/623/e346.abstract N2 - Background Knowledge is sparse on the prevalence of suspicion of cancer and other serious diseases in general practice. Likewise, little is known about the possible implications of this suspicion on future healthcare use and diagnoses.Aim To study the prevalence of GPs’ suspicions of cancer or other serious diseases and analyse how this suspicion predicted the patients’ healthcare use and diagnoses of serious disease.Design and setting Prospective population-based cohort study of 4518 patients consulting 404 GPs in a mix of urban, semi-urban and rural practices in Central Denmark Region during 2008–2009.Method The GPs registered consultations in 1 work day, including information on their suspicion of the presence of cancer or another serious disease. The patients were followed up for use of healthcare services and new diagnoses through the use of national registers.Results Prevalence of suspicion was 5.7%. Suspicion was associated with an increase in referrals (prevalence ratio [PR] = 2.56, 95% confidence interval [CI] = 2.22 to 2.96), especially for diagnostic imaging (PR = 3.95, 95% CI = 2.80 to 5.57), increased risk of a new diagnosis of cancer or another serious disease within 2 months (hazard ratio [HR] = 2.98, 95% CI = 1.93 to 4.62) — especially for cancer (HR = 7.55, 95% CI = 2.66 to 21.39) — and increased use of general practice (relative risk [RR] = 1.14, 95% CI = 1.06 to 1.24) and hospital visits (RR = 1.90, 95% CI = 1.62 to 2.23). The positive predictive value of a GP suspicion was 9.8% (95% CI = 6.4 to 14.1) for cancer or another serious disease within 2 months.Conclusion A GP suspicion of serious disease warrants further investigation, and the organisation of the healthcare system should ensure direct access from the primary sector to specialised tests. ER -